1. Anti-obesity therapies;Melnikova;Nat. Rev. Drug Discov.,2006
2. Plasma phentermine levels, weight loss and side-effects;Douglas;Int. J. Obes.,1983
3. Management of obesity and cardiometabolic risk-role of phentermine/extended release topiramate;Sweeting;Diabetes Metab. Syndr. Obes.: Targets Ther.,2014
4. Efficacy and safety of topi-ramate in the treatment of obese subjects with essential hypertension;Tonstad;Am. J. Cardiol.,2005
5. New Drug Application 22580: VI-052 Qnexa (phentermine/topiramate);Food and Drug Administration,2012